Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2019 16:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience Reports First Quarter 2019 Financial Results and Company Update

SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the first quarter ended March 31, 2019...
May 08, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-FRT1, a Potential Therapy for Preterm Birth and Fertility, in Drug Delivery and Translational Research

SAN DIEGO, May 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Pharmacokinetics and tolerability of a...
May 07, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience to Host First Quarter 2019 Financial Results and Company Update Conference Call and Webcast

SAN DIEGO, May 07, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30...
April 15, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Dr. James Simon, Award-Winning Physician, Presents on Ovaprene® as a Promising Novel Non-Hormonal Contraceptive Method in Clinical Development

SAN DIEGO, April 15, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced Ovaprene’s inclusion in a presentation to physicians on the...
April 09, 2019 08:45 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. Prices Underwritten Public Offering of Common Stock

SAN DIEGO, April 09, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), today announced the pricing of an underwritten public offering of 4,575,000 shares of its common stock at a price...
April 08, 2019 16:28 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. Announces Proposed Public Offering of Common Stock

SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that it intends to offer shares of its common stock in an...
April 08, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience Announces Publication of Pharmacokinetics Study of DARE-HRT1, a Potential Hormone Replacement Therapy, in the Journal of Pharmaceutical Sciences

SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Pharmacokinetics and tolerability of a...
April 01, 2019 16:30 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. Regains Listing Compliance on Nasdaq

SAN DIEGO, April 01, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it received notice from The Nasdaq Stock Market LLC...
April 01, 2019 08:00 ET | Source: Dare Bioscience, Inc.

Daré Bioscience, Inc. to Host Business Update and Full Year 2018 Financial Results Conference Call and Webcast

SAN DIEGO, April 01, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 8:30...
March 29, 2019 08:00 ET | Source: Dare Bioscience, Inc.

World-renowned Scientist, Described as the Edison of Medicine by Forbes Magazine, Dr. Robert Langer Joins Daré Bioscience Scientific Advisory Board

SAN DIEGO, March 29, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, announced that Dr. Robert Langer, co-inventor of Daré‘s novel, segmented...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right